BrightSpring Health Services Announces CareMed Was Selected as a National Specialty Pharmacy Partner for Leqembi®
07 November 2024 - 8:35AM
BrightSpring Health Services (“BrightSpring” or “BrightSpring
Health Services”) (NASDAQ: BTSG) is proud that CareMed, a
BrightSpring company and leading independent Specialty Pharmacy,
was selected by Eisai to be the national specialty pharmacy
provider for Leqembi®, a cutting-edge treatment for Alzheimer’s
disease.
“We’re proud of the work CareMed is doing with manufacturers and
prescribers to improve and extend the lives of patients living with
mild cognitive impairment and dementia, bringing more treatment
options to Alzheimer’s disease,” said BrightSpring’s
President and CEO, Jon Rousseau. “CareMed’s partnership
with Eisai shows their strong commitment to increasing patient
access to innovative medications and treatments, while delivering
comprehensive support and care to patients and their loved
ones."
Leqembi is a monoclonal antibody directed against aggregated
soluble and insoluble forms of amyloid beta in the treatment of
Alzheimer’s disease. The medication was tested in numerous clinical
trials with patients diagnosed with mild cognitive impairment or
mild dementia stage of disease. The FDA approval of Leqembi is
based on the results of the Phase III clinical trial, which
compared Leqembi to placebo in patients 50 to 90 years of
age with early Alzheimer’s disease. The study randomized 1795
patients in a 1:1 ratio to receive either intravenous Leqembi or
placebo. Patients who received Leqembi showed slowed progression of
cognitive impairment over an 18-month period compared to those
taking the placebo.
“At CareMed, we’re constantly looking for new opportunities to
expand our portfolio of breakthrough treatments and therapies for
patients living with devastating diseases,” said Benito
Fernandez, Chief Commercial Officer. “We’re proud to be in
the specialty pharmacy network for Leqembi. We’re confident this
new medication will help more patients with Alzheimer’s get the
right treatment to improve their quality of life.”
To learn more about CareMed and BrightSpring, please visit
https://www.brightspringhealth.com/.
About BrightSpring Health Services:BrightSpring
Health Services provides complementary and integrated home- and
community-based pharmacy and health solutions for complex
populations in need of specialized and/or chronic care.
Through the Company’s service lines, including pharmacy, home
health care and primary care, and rehabilitation and behavioral
health, we provide comprehensive care and clinical solutions in all
50 states to over 400,000 customers, clients and patients
daily.
About CareMed Specialty Pharmacy:CareMed is an
independent Specialty Pharmacy and clinical support services
company within the BrightSpring enterprise. CareMed was founded to
bring together the stakeholders involved in the chronic and rare
disease treatment process and serve the specialized needs of
patients, providers, hospitals, manufacturers, health plans, and
payers. CareMed is headquartered in New Hyde Park, New York, and is
a flagship specialty pharmacy brand of PharMerica Corporation, a
leading institutional pharmacy, specialty infusion, and hospital
services company servicing healthcare facilities in the United
States. It is accredited through URAC, ACHC, and NAPB as a Digital
Pharmacy. For more information about CareMed, please visit
CareMedSP.com.
Media Contact
Leigh WhiteLeigh.white@brightspringhealth.com 502.630.7412
BrightSpring Health Serv... (NASDAQ:BTSG)
Historical Stock Chart
From Oct 2024 to Nov 2024
BrightSpring Health Serv... (NASDAQ:BTSG)
Historical Stock Chart
From Nov 2023 to Nov 2024